COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials

A listing of COPD (Chronic Obstructive Pulmonary Disease) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alabama

TR31
Anniston Alabama 36207

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

TR20
Birmingham Alabama 35216

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

TR7
Birmingham Alabama 35209

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

View More ▼

UPDATED

Andalusia Alabama

A clinical trial to evaluate treatments using olodaterol and tiotropium for patients with Chronic Obstructive Pulmonary Disease

UPDATED

Andalusia Alabama

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

UPDATED

Birmingham Alabama 35233

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

UPDATED

Birmingham Alabama

A clinical trial to evaluate treatments using olodaterol and tiotropium for patients with Chronic Obstructive Pulmonary Disease

UPDATED

Birmingham Alabama

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

UPDATED

Florence Alabama

A clinical trial to evaluate treatments using olodaterol and tiotropium for patients with Chronic Obstructive Pulmonary Disease

UPDATED

Jasper Alabama

A clinical trial to evaluate treatments using olodaterol and tiotropium for patients with Chronic Obstructive Pulmonary Disease

Andalusia Alabama

A clinical research study of GFF MDI (PT003), FF MDI (PT005), GP MDI (PT001) and Placebo MDI for the treatment of COPD, Severe

Andalusia Alabama 36420

A clinical research study of SUN-101 and Placebo for the treatment of COPD or Chronic Obstructive Pulmonary Disease

Athens Alabama 35611

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Birmingham Alabama 35216

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Birmingham Alabama 35215

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Birmingham Alabama 35294

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Birmingham Alabama

A clinical research study of GFF MDI (PT003), FF MDI (PT005), GP MDI (PT001) and Placebo MDI for the treatment of COPD, Severe

Birmingham Alabama 35294

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Birmingham Alabama 35294

A Phase 2 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Birmingham Alabama

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Birmingham Alabama 35209

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Birmingham Alabama 35209

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Florence Alabama 35630

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Florence Alabama 35630

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Foley Alabama

A clinical research study of GFF MDI (PT003), FF MDI (PT005), GP MDI (PT001) and Placebo MDI for the treatment of COPD, Severe

Foley Alabama 36535

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Gulf Shores Alabama

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Huntsville Alabama 35801

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Jasper Alabama 35501

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Jasper Alabama

A clinical research study of GFF MDI (PT003), FF MDI (PT005), GP MDI (PT001) and Placebo MDI for the treatment of COPD, Severe

Jasper Alabama 35501

A clinical research study of SUN-101 and Placebo for the treatment of COPD or Chronic Obstructive Pulmonary Disease

Jasper Alabama 35501

A clinical trial to evaluate treatments using UMEC/VI DPI, Placebo DPI and Albuterol/salbutamol MDI for patients with Pulmonary Disease, Chronic Obstructive

Jasper Alabama 35501

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Mobile Alabama 36608

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Mobile Alabama 36604

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Montgomery Alabama

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Muscle Shoals Alabama 35662

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Sheffield Alabama 35660

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Arizona

TR14
Flagstaff Arizona 86001

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Arizona Research Center
Phoenix Arizona 85023

A Long-Term, Randomized, Double-Blind Study of the Safety, Tolerability and Efficacy of Aclidinium Bromide At Two Dosage Levels When Administered to Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease

TR47
Phoenix Arizona 85020

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

TR76
Phoenix Arizona 85018

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

TR79
Phoenix Arizona 85381

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Elite Clinical Studies, LLC
Phoenix Arizona 85018

Is COPD Leaving You Breathless? Right now we're enrolling adults with COPD ages 40 or older in a research study of an investigational medication for COPD.

TR46
Tucson Arizona 85741

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

View More ▼

UPDATED

Flagstaff Arizona 86001

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

UPDATED

Flagstaff Arizona

A clinical trial to evaluate treatments using olodaterol and tiotropium for patients with Chronic Obstructive Pulmonary Disease